Company · SXTP · CIK 1946563

60 Degrees Pharmaceuticals, Inc. (SXTP) SEC filings and CIK.

SXTP’s SEC Central Index Key (CIK) is 0001946563, or 1946563 without leading zeros. The SEC’s ticker file lists it as 60 DEGREES PHARMACEUTICALS, INC.. The same CIK also trades as SXTPW.

Ticker
SXTP
CIK
0001946563
Other tickers
SXTPW
Insider transactions, Q3 2026
0

Insider trading

In Q3 2026, insiders at 60 Degrees Pharmaceuticals, Inc. reported 0 non-derivative transactions on 1 Forms 3, 4 and 5, including 0 open-market purchases and 0 sales.

Recent filings we observed

From our record of EDGAR’s latest-filings feed and sampled daily indexes. Not a complete filing history; use the filings API for that.
FiledFormAccession
2026-11-068-K0001213900-26-116620

Get SXTP SEC data through the API

Filing history
curl "https://sec-api.dev/api/v1/filings?cik=1946563&limit=10" \
  -H "Authorization: Bearer $SEC_API_KEY"
Company profile
curl "https://sec-api.dev/api/v1/companies/1946563" \
  -H "Authorization: Bearer $SEC_API_KEY"
Reported XBRL facts
curl "https://sec-api.dev/api/v1/facts/1946563?taxonomy=us-gaap&concept=Revenues&limit=10" \
  -H "Authorization: Bearer $SEC_API_KEY"

Ticker to CIK API · SEC filings API · 60 Degrees Pharmaceuticals, Inc. on SEC.gov

Questions

What is SXTP’s CIK number?

SXTP’s SEC Central Index Key (CIK) is 0001946563, or 1946563 without leading zeros. The SEC’s ticker file lists it as 60 DEGREES PHARMACEUTICALS, INC.. The same CIK also trades as SXTPW.

How do I find 60 Degrees Pharmaceuticals, Inc.’s 10-K?

Request /api/v1/filings?cik=1946563&form=10-K, or open the company’s EDGAR page and filter by 10-K. Foreign issuers file 20-F or 40-F instead.

Ticker and CIK: SEC company_tickers.json, cached 2026-11-02. Tickers can move between entities; the CIK identifies the filer.

Plain-text version for agents and LLMs: /companies/sxtp.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.